BR112023026029A2 - Composições de goma gelana e método para sua preparação - Google Patents

Composições de goma gelana e método para sua preparação

Info

Publication number
BR112023026029A2
BR112023026029A2 BR112023026029A BR112023026029A BR112023026029A2 BR 112023026029 A2 BR112023026029 A2 BR 112023026029A2 BR 112023026029 A BR112023026029 A BR 112023026029A BR 112023026029 A BR112023026029 A BR 112023026029A BR 112023026029 A2 BR112023026029 A2 BR 112023026029A2
Authority
BR
Brazil
Prior art keywords
gellan gum
preparation
gum compositions
compositions
lyophilized
Prior art date
Application number
BR112023026029A
Other languages
English (en)
Inventor
Gary Yewey
Jaakko Johannes Kesti Matti
Original Assignee
Auregen Biotherapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auregen Biotherapeutics Sa filed Critical Auregen Biotherapeutics Sa
Publication of BR112023026029A2 publication Critical patent/BR112023026029A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

composições de goma gelana e método para sua preparação. a presente invenção refere-se geralmente ao campo dos biopolímeros. em um aspecto, a invenção é dirigida a um método de preparação de composições de goma gelana liofilizadas e reconstituídas. em aspectos adicionais, a invenção refere-se a composições liofilizadas compreendendo goma gelana, composições de goma gelana reconstituídas, formulações de dosagem unitária compreendendo goma gelana liofilizada e seu uso em medicina ou outras aplicações estéreis.
BR112023026029A 2021-06-16 2022-06-14 Composições de goma gelana e método para sua preparação BR112023026029A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21179842 2021-06-16
PCT/EP2022/066099 WO2022263405A1 (en) 2021-06-16 2022-06-14 Gellan gum compositions and method for their preparation

Publications (1)

Publication Number Publication Date
BR112023026029A2 true BR112023026029A2 (pt) 2024-02-27

Family

ID=76829254

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023026029A BR112023026029A2 (pt) 2021-06-16 2022-06-14 Composições de goma gelana e método para sua preparação

Country Status (9)

Country Link
EP (1) EP4355791A1 (pt)
JP (1) JP2024522780A (pt)
KR (1) KR20240043740A (pt)
CN (1) CN118055953A (pt)
AU (1) AU2022292071A1 (pt)
BR (1) BR112023026029A2 (pt)
CA (1) CA3222229A1 (pt)
IL (1) IL309404A (pt)
WO (1) WO2022263405A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3671269B2 (ja) * 1996-12-27 2005-07-13 三栄源エフ・エフ・アイ株式会社 乾燥ゲル及びそれから調製されるゼリー
US6485747B1 (en) * 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
US9579417B2 (en) * 2013-04-09 2017-02-28 Association For The Advancement Of Tissue Engineering And Cell Based Technologies And Therapies-A4Tec Gellan gum spongy-like hydrogel, its preparation and biomedical applications thereof
PL3230044T3 (pl) 2014-12-11 2021-02-08 ETH Zürich Przeszczep rusztowania do naprawy chrząstki i sposób jego wytwarzania

Also Published As

Publication number Publication date
EP4355791A1 (en) 2024-04-24
JP2024522780A (ja) 2024-06-21
KR20240043740A (ko) 2024-04-03
CN118055953A (zh) 2024-05-17
WO2022263405A1 (en) 2022-12-22
CA3222229A1 (en) 2022-12-22
IL309404A (en) 2024-02-01
AU2022292071A1 (en) 2024-01-04

Similar Documents

Publication Publication Date Title
Sierra-García et al. Acemannan, an extracted polysaccharide from Aloe vera: A literature review
BR112012022669A2 (pt) composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina.
de Carvalho et al. Evidence-based studies and perspectives of the use of Brazilian green and red propolis in dentistry
BR112012022800A2 (pt) composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
BRPI0907087A2 (pt) ácidos nucleicos de fórmula (i) (nuglxmgnnv)a e derivados dos mesmos como um agente imunoestimulante/adjuvante
Gavan et al. Development and evaluation of hydrogel wound dressings loaded with herbal extracts
BR112023003948A2 (pt) Compostos de antagonista de quinolina cgas
BR112015009280A2 (pt) preparações liofilizadas de melfalana flufenamida
Tarbet et al. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus
Jackson et al. Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons
MX351380B (es) Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.
Arora et al. Synergistic effect of plant extracts on endodontic pathogens isolated from teeth with root canal treatment failure: an in vitro study
Fallah et al. Molecular docking investigation of antiviral herbal compounds as potential inhibitors of SARS-CoV-2 spike receptor
Walzer et al. Medical plant extracts for treating knee osteoarthritis: a snapshot of recent clinical trials and their biological background
BR112022013322A2 (pt) Derivado de tetra-hidroisoquinolina tricíclico, método de preparação para o mesmo e aplicação do mesmo em medicina
Prasad et al. Evaluation of antimicrobial efficacy of neem and Aloe vera leaf extracts in comparison with 3% sodium hypochlorite and 2% chlorhexidine against E. faecalis and C. albicans
BR112023026029A2 (pt) Composições de goma gelana e método para sua preparação
BR112015023806A2 (pt) Novos regimes de dosagem de celgosivir para o tratamento de dengue
CY1116245T1 (el) Φαρμακευτικη συνθεση η οποια εχει αντιμικροβιακη και ταχεια επουλωτικη δραστικοτητα για εξωτερικη χορηγηση, και διεργασια για την παρασκευη αυτης
CL2022003426A1 (es) Composición farmacéutica acuosa de levilimab y su uso
Koech et al. Anti-inflammatory activity of dichloromethanolic root extract of Clutia abyssinica in Swiss Albino Mice
Juhairiyah et al. Ascariasis di Kalimantan Selatan
BR112021024546A2 (pt) Compostos tricíclicos e uso dos mesmos
Baskaran et al. Synthesis and characterization of nisin-incorporated alpha-tricalcium phosphate for pulp capping–An in vitro study
Gafar et al. Effect of Gum Arabic on plaque-induced gingivitis: A randomised controlled trial